TotalMarketCap

Assembly Biosciences

ASMBNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$401.715 M

$19.73 -0.70%

Close of 6 Nov 2026

As of 6 Nov 2026, Assembly Biosciences (ASMB) has a market capitalization of $401.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$72.3M

#2592 by revenue

Earnings

-$6.12M

Loss-making

Shares outstanding

20,360,596

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #204Relmada TherapeuticsRLMD$402.7M
  2. #205MapLight TherapeuticsMPLT$402.2M
  3. #206Assembly BiosciencesASMB$401.7M
  4. #207KamadaKMDA$397.0M
  5. #208BlossomHill TherapeuticsBLSM$385.2M

What if Assembly Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,386,839

Per share 70,291× higher

Bitcoin $1.53T

$75,039.46

Per share 3,803× higher

Apple $5.02T

$246,347.53

Per share 12,486× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Assembly Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.